心脑血管中药复方专利发展进程及影响因素

发布时间：2018-01-08 21:30

本文关键词：心脑血管中药复方专利发展进程及影响因素　出处：《中华中医药杂志》2016年10期 　论文类型：期刊论文

【摘要】：目的:研究心脑血管中药复方专利发展进程及影响因素。方法:将国家知识产权局专利数据库、中国专利信息中心及相关事务所作为专利数据来源;以万方数据库、CNKI、CHKD数据库作为科研成果检索资源;运用简单统计与聚类分析的方法,把年度数据当作聚类成员,以心脑血管中药复方专利申请量、公开量、科研成果作为聚类变量,对20年来心脑血管中药复方专利展开聚类分析。结果:心脑血管中药复方专利在20年的时间里经历了3个阶段:1991至2000年是第一阶段,专利申请量、公开量、科研论文数量较低;第二阶段为2001至2004年,专利申请量、公开量是第一阶段的2倍,而科研论文数是第一阶段的3倍;第三阶段是2005年至2010年,3个指标均为第二阶段的2倍。结论:心脑血管中药复方专利的发展与国家政策、专利制度、中医药科研等因素密切相关。
[Abstract]:Objective: to study the development process and influencing factors of the patent of cardio-cerebrovascular Chinese medicine compound. Methods: the patent database of the State intellectual property Office, the China Patent Information Center and the related firms were used as the source of patent data. The CNKI / CHKD database was used as the retrieval resource of scientific research results. Using simple statistics and cluster analysis method, the annual data as cluster members, cardio-cerebrovascular traditional Chinese medicine compound patent application amount, open volume, scientific research results as clustering variables. Cluster analysis was carried out on the patent of cardio-cerebrovascular traditional Chinese medicine compound in the past 20 years. Results: the patent of cardio-cerebrovascular Chinese medicine compound patent went through three stages from 1991 to 2000 in 20 years. The first stage was from 1991 to 2000. The amount of patent application, the quantity of open and the quantity of scientific research papers are relatively low; The second stage is from 2001 to 2004, the number of patent applications is twice as large as that of the first stage, and the number of scientific papers is three times that of the first stage. The third stage was from 2005 to 2010, and the three indexes were twice as much as those in the second stage. Conclusion: the development and national policy and patent system of cardio-cerebrovascular Chinese medicine compound patent. Factors such as scientific research of traditional Chinese medicine are closely related.
【作者单位】：河北中医学院;北京中医药大学第三附属医院;
【基金】：河北省教育厅基金项目(No.QN20131073)~~
【分类号】：R287;G306
【正文快照】： Development process and influence factors of Chinese medicine compound prescriptionpatent for cardiovascular and cerebrovascular diseaseYANG Xu-jie1,PEI Xiao-hua2,WANG Chun-hui2(1Hebei University of Chinese Medicine,Shijiazhuang 050200,China;2Beijing Uni

【相似文献】